2025
SJR Q2
JCR Q3 · 2,2
644 eşleşen makale
SCIE
Dergi ayrıntısı
Drug and Chemical Toxicology
- Yayıncı
- Taylor and Francis Ltd.
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0148054515256014
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,535
- Quartile Q2
- H-Index 60
- Atıf/yayın 2,62
- Doküman (3y) 549
- Atıf (3y) 1.575
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,2
- 5Y JIF 2,5
- JCI 0,47
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Chemical Health and Safety Q3
- Health, Toxicology and Mutagenesis Q3
- Medicine (miscellaneous) Q2
- Pharmacology Q3
- Public Health, Environmental and Occupational Health Q2
- Toxicology Q3
Alanlar
- Chemical Engineering
- Environmental Science
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Chemistry, Multidisciplinary | Pharmacology & Pharmacy | Toxicology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,535 | 2,2 | 2,5 | 0,47 | Q2 | 60 |
| 2024 | Q2 | Q3 | 0,538 | 1,9 | 2,4 | 0,5 | Q2 | 57 |
| 2023 | Q2 | Q3 | 0,542 | 2,1 | 2,4 | 0,56 | Q2 | 57 |
| 2022 | Q2 | Q3 | 0,507 | 2,6 | 2,8 | 0,64 | Q2 | 57 |
| 2021 | Q3 | Q3 | 0,402 | 2,6 | 2,5 | 0,62 | Q2 | 57 |
| 2020 | Q3 | Q2 | 0,422 | 3,4 | 2,6 | 0,68 | Q2 | 57 |
| 2019 | Q3 | Q3 | 0,422 | 2,4 | 2 | 0,52 | Q2 | 57 |
| 2018 | — | Q3 | — | 1,9 | 2 | 0,5 | Q2 | — |
| 2017 | Q2 | Q3 | 0,46 | 1,5 | 1,5 | 0,46 | Q2 | 57 |
| 2016 | Q2 | Q3 | 0,542 | 1,7 | 1,5 | — | — | 57 |
| 2015 | Q2 | Q3 | 0,498 | 1,7 | 1,4 | — | — | 57 |
| 2014 | Q2 | Q3 | 0,453 | 1,2 | 1,1 | — | — | 57 |
| 2013 | Q2 | Q3 | 0,406 | 1,1 | 1,1 | — | — | 57 |
| 2012 | Q2 | Q3 | 0,39 | 1,3 | 1,1 | — | — | 57 |
| 2011 | Q2 | Q3 | 0,371 | 1,1 | 1,3 | — | — | 57 |
| 2010 | Q2 | Q3 | 0,34 | 1 | 1 | — | — | 57 |
| 2009 | — | Q2 | — | 1,2 | 1,3 | — | — | — |
| 2008 | — | Q2 | — | 1,4 | 1,2 | — | — | — |
| 2007 | — | Q2 | — | 1,1 | 1,1 | — | — | — |
| 2006 | — | Q2 | — | 1,2 | — | — | — | — |
| 2005 | — | Q2 | — | 1 | — | — | — | — |
| 2004 | — | Q3 | — | 0,7 | — | — | — | — |
| 2003 | — | Q3 | — | 0,5 | — | — | — | — |
| 2002 | — | Q2 | — | 0,9 | — | — | — | — |
| 2001 | — | Q2 | — | 0,8 | — | — | — | — |
| 2000 | — | Q3 | — | 0,6 | — | — | — | — |
| 1999 | — | Q3 | — | 0,5 | — | — | — | — |
| 1998 | — | Q3 | — | 0,5 | — | — | — | — |
| 1997 | — | Q3 | — | 0,5 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 159/250 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 231/356 |
| 2025 | TOXICOLOGY | SCIE | Q3 | Q4 | 79/106 |
| 2024 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 153/239 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 238/352 |
| 2024 | TOXICOLOGY | SCIE | Q4 | Q4 | 82/106 |
| 2023 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 130/231 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 210/354 |
| 2023 | TOXICOLOGY | SCIE | Q3 | Q3 | 78/106 |
| 2022 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 103/178 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 183/278 |
| 2022 | TOXICOLOGY | SCIE | Q3 | Q3 | 63/94 |
| 2021 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 110/179 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 199/279 |
| 2021 | TOXICOLOGY | SCIE | Q4 | Q3 | 76/94 |
| 2020 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | Q2 | 82/178 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 142/276 |
| 2020 | TOXICOLOGY | SCIE | Q3 | Q3 | 47/93 |
| 2019 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 89/177 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 163/271 |
| 2019 | TOXICOLOGY | SCIE | Q3 | Q4 | 57/92 |
| 2018 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 98/172 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 184/267 |
| 2018 | TOXICOLOGY | SCIE | Q4 | Q4 | 71/93 |
| 2017 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | Q2 | 104/171 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 206/261 |
| 2017 | TOXICOLOGY | SCIE | Q4 | Q4 | 78/94 |
| 2016 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 89/166 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 185/257 |
| 2016 | TOXICOLOGY | SCIE | Q3 | — | 69/92 |
| 2015 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 85/163 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 180/255 |
| 2015 | TOXICOLOGY | SCIE | Q4 | — | 68/90 |
| 2014 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 89/157 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 198/255 |
| 2014 | TOXICOLOGY | SCIE | Q4 | — | 73/88 |
| 2013 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 95/148 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 202/256 |
| 2013 | TOXICOLOGY | SCIE | Q4 | — | 73/87 |
| 2012 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 81/152 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 190/261 |
| 2012 | TOXICOLOGY | SCIE | Q4 | — | 70/85 |
| 2011 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 88/154 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 204/261 |
| 2011 | TOXICOLOGY | SCIE | Q4 | — | 68/83 |
| 2010 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 81/147 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 203/252 |
| 2010 | TOXICOLOGY | SCIE | Q4 | — | 69/83 |
| 2009 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 70/140 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 180/237 |
| 2009 | TOXICOLOGY | SCIE | Q4 | — | 60/77 |
| 2008 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 58/127 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 158/219 |
| 2008 | TOXICOLOGY | SCIE | Q4 | — | 58/75 |
| 2007 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 63/128 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 162/205 |
| 2007 | TOXICOLOGY | SCIE | Q4 | — | 60/73 |
| 2006 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 52/124 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 144/199 |
| 2006 | TOXICOLOGY | SCIE | Q3 | — | 56/76 |
| 2005 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 58/125 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 155/193 |
| 2005 | TOXICOLOGY | SCIE | Q4 | — | 57/75 |
| 2004 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 72/125 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 157/187 |
| 2004 | TOXICOLOGY | SCIE | Q4 | — | 60/75 |
| 2003 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 82/123 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 168/185 |
| 2003 | TOXICOLOGY | SCIE | Q4 | — | 67/77 |
| 2002 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 48/119 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 134/188 |
| 2002 | TOXICOLOGY | SCIE | Q3 | — | 56/76 |
| 2001 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q2 | — | 54/118 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 136/186 |
| 2001 | TOXICOLOGY | SCIE | Q4 | — | 60/78 |
| 2000 | CHEMISTRY, MULTIDISCIPLINARY | SCIE | Q3 | — | 68/118 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 148/181 |
| 2000 | TOXICOLOGY | SCIE | Q4 | — | 65/77 |
| 1999 | CHEMISTRY | SCIE | Q3 | — | 76/121 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 150/175 |
| 1999 | TOXICOLOGY | SCIE | Q4 | — | 66/74 |
| 1998 | CHEMISTRY | SCIE | Q3 | — | 72/126 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 146/178 |
| 1998 | TOXICOLOGY | SCIE | Q4 | — | 57/71 |
| 1997 | CHEMISTRY | SCIE | Q3 | — | 74/111 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 131/157 |
| 1997 | TOXICOLOGY | SCIE | Q4 | — | 50/63 |